Inés López‐Cuenca

ORCID: 0000-0003-0511-515X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glaucoma and retinal disorders
  • Retinal Imaging and Analysis
  • Retinal Diseases and Treatments
  • Retinal Development and Disorders
  • Alzheimer's disease research and treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neurological Disease Mechanisms and Treatments
  • Neurological Disorders and Treatments
  • Amyotrophic Lateral Sclerosis Research
  • Saffron Plant Research Studies
  • Retinal and Optic Conditions
  • Genetic Neurodegenerative Diseases
  • Ophthalmology and Visual Impairment Studies
  • Dementia and Cognitive Impairment Research
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Vasculitis and related conditions
  • Biochemical effects in animals
  • Biomedical Text Mining and Ontologies
  • Mitochondrial Function and Pathology
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Neonatal and fetal brain pathology
  • Parkinson's Disease Mechanisms and Treatments
  • Cerebral Venous Sinus Thrombosis
  • Flavonoids in Medical Research
  • Machine Learning in Healthcare

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
2021-2025

Universidad Complutense de Madrid
2017-2025

Hospital Clínico San Carlos
2022-2024

Instituto de Salud Carlos III
2021-2022

Instituto Ramón y Cajal de Investigación Sanitaria
2017-2022

Glaucoma is a neurodegenerative disease of the retina characterized by irreversible loss retinal ganglion cells (RGCs) leading to visual loss. Degeneration RGCs and their axons, as well damage remodeling lamina cribrosa are main events in pathogenesis glaucoma. Different molecular pathways involved RGC death, which triggered exacerbated consequence number risk factors such elevated intraocular pressure (IOP), age, ocular biomechanics, or low perfusion pressure. Increased IOP one most...

10.3389/fncel.2024.1354569 article EN cc-by Frontiers in Cellular Neuroscience 2024-01-25

Alzheimer's Disease (AD) can cause degeneration in the retina and optic nerve either directly, as a result of amyloid beta deposits, or secondarily, degradation visual cortex. These effects raise possibility that tracking ophthalmologic changes be used to assess neurodegeneration AD. This study aimed detect retinal associated functional three groups patients consisting AD with mild disease, moderate disease healthy controls by using non-invasive psychophysical ophthalmological tests optical...

10.1371/journal.pone.0220535 article EN cc-by PLoS ONE 2019-08-15

Glaucoma is a neurodegenerative disease characterized by the loss of retinal ganglion cells (RGCs). An increase in intraocular pressure principal risk factor for such loss, but controlling this does not always prevent glaucomatous damage. Activation immune resident retina (microglia) may contribute to RGC death. Thus, substance with anti-inflammatory activity protect against degeneration. This study investigated neuroprotective and effects hydrophilic saffron extract standardized 3% crocin...

10.3390/ijms20174110 article EN International Journal of Molecular Sciences 2019-08-22

The murine models of Alzheimer’s disease (AD) have advanced our understanding the pathophysiology. In vivo studies retina using optical coherence tomography (OCT) complemented histological methods; however, lack standardisation in OCT methodologies for AD has led to significant variations results different studies. A literature search PubMed and Scopus been performed review methods used these analyse methodological characteristics each study. addition, some recommendations are offered...

10.3390/biomedicines12030528 article EN cc-by Biomedicines 2024-02-27

In Alzheimer’s disease (AD), vascular changes could be caused by amyloid beta (Aβ) aggregates replacing the contractile smooth musculature of arteriole walls. These happen in brain network, but also eye, and are related to decreased density low blood flow. patients with disease, thinning choroid retina has been shown. The aim this prospective study was assess retinal choroidal systems, analyzing thickness optical coherence tomography (OCT), foveal avascular zone (FAZ) OCT-angiography (OCTA),...

10.3390/jpm10040231 article EN Journal of Personalized Medicine 2020-11-15

Signaling mediated by cytokines and chemokines is involved in glaucoma-associated neuroinflammation the damage of retinal ganglion cells (RGCs). Using multiplexed immunoassay immunohistochemical techniques a glaucoma mouse model at different time points after ocular hypertension (OHT), we analyzed (i) expression pro-inflammatory cytokines, anti-inflammatory BDNF, VEGF, fractalkine; (ii) number Brn3a+ RGCs. In OHT eyes, there was an upregulation IFN-γ days 3, 5, 15; IL-4 1, 7 IL-10 3 5...

10.3390/ijms22042066 article EN International Journal of Molecular Sciences 2021-02-19

Alzheimer's disease (AD) is the most common type of dementia in world. The main biomarkers associated with AD are protein amyloid-β (Aβ) plaques and tau neurofibrillary tangles, which responsible for brain neuroinflammation mediated by microglial cells. Increasing evidence has shown that retina can also be affected AD, presenting some molecular cellular changes brain, such as microglia activation. However, there only a few studies assessing retinal animal models AD. These use sections, have...

10.3390/ijms21030816 article EN International Journal of Molecular Sciences 2020-01-27

Abstract Background Two main genetic risks for sporadic Alzheimer’s disease (AD) are a family history and ɛ4 allele of apolipoprotein E. The brain retina part the central nervous system share pathophysiological mechanisms in AD. Methods We performed cross-sectional study with 30 participants without AD (FH−) noncarriers ApoE (ApoE ɛ4−) as control group 34 (FH+) carriers at least one ɛ4+). analyzed correlations between macular volumes retinal layers thickness peripapillary nerve fiber layer...

10.1186/s13195-022-01008-5 article EN cc-by Alzheimer s Research & Therapy 2022-06-04

Abstract Background The earliest pathological features of Alzheimer’s disease (AD) appear decades before the clinical symptoms. pathology affects brain and eye, leading to retinal structural changes functional visual alterations. Healthy individuals at high risk developing AD present alterations in these ophthalmological measures, as well resting-state electrophysiological activity. However, it is unknown whether are related visual-related Elucidating this relationship paramount understand...

10.1186/s13195-023-01166-0 article EN cc-by Alzheimer s Research & Therapy 2023-01-24

Aims/Purpose: Transgenic mouse models of Alzheimer's disease (AD) have shown a correlation between retinal abnormalities and brain pathology. The APP NL‐F/NL‐F murine humanized AD model accurately replicates many pathological features seen in patients. This study aims to analyze, using manual segmentation by optical coherence tomography (OCT), the changes occurring several layers at 6, 9, 12, 15, 17, 20 months age, comparison C57BL/6J mice (WT). Methods: A diachronic was conducted OCT for...

10.1111/aos.17032 article EN Acta Ophthalmologica 2025-01-01

Aims/Purpose: Transgenic mouse models of Alzheimer's disease (AD) have shown a correlation between retinal abnormalities and brain pathology. The APP NL‐F/NL‐F murine humanized AD model accurately replicates many pathological features seen in patients. This study aims to analyze, using manual segmentation by optical coherence tomography (OCT), the changes occurring several layers at 6, 9, 12, 15, 17, 20 months age, comparison C57BL/6J mice (WT). Methods: A diachronic was conducted OCT for...

10.1111/aos.17417 article EN Acta Ophthalmologica 2025-01-01

Aims/Purpose: To present real‐world clinical data on the effectiveness of brolucizumab in managing neovascular age‐related macular degeneration (nAMD), either as primary therapy or switch therapy, a tertiary care eye hospital London. Methods: This research involved 37 eyes diagnosed with nAMD, all which received intravitreal injections brolucizumab. The main metrics assessed were changes best corrected visual acuity (BCVA) and central retinal thickness (CRT) by optical coherence tomography...

10.1111/aos.17342 article EN Acta Ophthalmologica 2025-01-01

Aims/Purpose: To present real‐world clinical data on the effectiveness of brolucizumab in managing neovascular age‐related macular degeneration (nAMD), either as primary therapy or switch therapy, a tertiary care eye hospital London. Methods: This research involved 37 eyes diagnosed with nAMD, all which received intravitreal injections brolucizumab. The main metrics assessed were changes best corrected visual acuity (BCVA) and central retinal thickness (CRT) by optical coherence tomography...

10.1111/aos.16991 article EN Acta Ophthalmologica 2025-01-01

Aims/Purpose: Treatments for glaucoma damage have focused on lowering intraocular pressure (IOP). However, despite controlled IOP, the neurodegenerative process continues. Therefore, it is necessary to study new molecules with neuroprotective properties treatment. The aim of this was investigate survival retinal ganglion cells (RGCs) in an experimental model ocular hypertension (OHT) following administration a combination citicoline and coenzyme Q10 (COQUN Combo). Methods: Four groups Swiss...

10.1111/aos.17111 article EN Acta Ophthalmologica 2025-01-01

Aims/Purpose: In Alzheimer's disease (AD), there are histopathological aspects that cannot be studied in patients, demanding the use of murine models disease. The APP NL‐F/NL‐F model reproduces pathophysiology quite faithfully. aim present study was to analyze retinal vascular structures and thickness an AD at different ages compares these findings age‐matched wild type (WT) controls. Methods: A diachronic conducted using spectral‐domain OCT angiography (SD‐OCTA) AngioTool software assess...

10.1111/aos.17424 article EN Acta Ophthalmologica 2025-01-01

Aims/Purpose: To investigate the anti‐inflammatory effects of citicoline and coenzyme Q10 (COQUN Combo) in an experimental model ocular hypertension (OHT). Methods: Swiss albino mice were used: vehicle control (Vehicle n = 6), COQUN Combo 5), laser (LG+Veh, (LG+COQUN Combo, 6). was administered daily with gelatin 15 days prior to induction 3 post‐induction LG+COQUN groups. The Vehicle LG+Veh groups received neutral gelatin. OHT induced left eye by photocoagulation limbal episcleral veins,...

10.1111/aos.17112 article EN Acta Ophthalmologica 2025-01-01

Aims/Purpose: In the last decades, retinal alterations have been shown by OCT in Alzheimer's disease (AD), initially affecting macular region early AD, and subsequently progressing to peripapillary retina, pointing out this tissue be considered for diagnosis follow‐up AD. This study aimed investigate changes patients with mild cognitive impairment (MCI), an intermediate stage between normal aging know if preclinical there are retina. Methods: Sixteen healthy subjects 16 MCI were included....

10.1111/aos.17349 article EN Acta Ophthalmologica 2025-01-01

Aims/Purpose: In Alzheimer's disease (AD), there are histopathological aspects that cannot be studied in patients, demanding the use of murine models disease. The APP NL‐F/NL‐F model reproduces pathophysiology quite faithfully. aim present study was to analyze retinal vascular structures and thickness an AD at different ages compares these findings age‐matched wild type (WT) controls. Methods: A diachronic conducted using spectral‐domain OCT angiography (SD‐OCTA) AngioTool software assess...

10.1111/aos.17063 article EN Acta Ophthalmologica 2025-01-01

Hydrocephalus, characterized by ventriculomegaly due to cerebrospinal fluid accumulation in the cerebral ventricles, is a co-morbidity factor several neurodevelopmental, psychiatric and neurodegenerative diseases. Aquaporin-4 (AQP4) crucial for brain water homeostasis, with Aqp4 knockout mice showing sporadic increased content. Kinase D interacting substrate of 220 kDa (Kidins220), transmembrane protein involved neuronal survival, synaptic activity neurogenesis, controls AQP4 levels...

10.1186/s12987-025-00626-z article EN cc-by-nc-nd Fluids and Barriers of the CNS 2025-02-12
Coming Soon ...